Literature DB >> 31371060

Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency Virus.

Fawaz Alenezi1, Gerald S Bloomfield2, Nwora Lance Okeke3, Poonam Velagapudi4, Loai Abudaqa5, Nkechinyere Ijioma6, Allison Dunning5, Hasan Alajmi5, Meredith E Clement3, Svati H Shah7, Susanna Naggie3, Eric J Velazquez8.   

Abstract

Improvement in survival in patients living with human immunodeficiency virus (PLHIV) has led to increased prevalence of cardiovascular disease. Whether HIV-associated immune dysfunction is associated with preclinical left ventricular (LV) dysfunction despite normal LV ejection fraction (LVEF) is unclear. Accordingly, we investigated the relation of immune status and LV function in PLHIV. Global longitudinal strain (GLS) analyses were performed retrospectively on all echocardiograms for PLHIV who had available HIV-1 RNA viral load, nadir, and proximal CD4 cell count data at Duke University Medical Center between 2001 and 2012. The relation between HIV-1 RNA viral load, nadir, and proximal CD4 count and GLS as a continuous dependent variable was assessed with unadjusted and adjusted linear regression. GLS was calculated for 253 PLHIV. Median GLS in our cohort was - 15.1% with interquartile range from (-16.7 to -13.6). All participants had an LVEF ≥50%. In adjusted analyses, proximal CD4 <500 cells/mm3 and nadir CD4 <250 cells/mm3 were significantly inversely correlated with GLS (p = 0.01 and p = 0.004, respectively). In PLHIV, patient with plasma HIV RNA <400 copies/ml at baseline had a trend toward significantly more negative values of GLS compared with those patients without viral suppression at baseline (p = 0.08). In conclusion, this study is the first to demonstrate such a high prevalence of abnormal GLS in PLHIV, and the first to identify that proximal and nadir CD4 cell count are independently associated with GLS despite normal LVEF.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31371060      PMCID: PMC6887515          DOI: 10.1016/j.amjcard.2019.06.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Cardiovascular disease in HIV: traditional and nontraditional risk factors.

Authors:  Steven K Grinspoon
Journal:  Top Antivir Med       Date:  2014 Sep-Oct

2.  State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.

Authors:  Steven K Grinspoon; Carl Grunfeld; Donald P Kotler; Judith S Currier; Jens D Lundgren; Michael P Dubé; Steven E Lipshultz; Priscilla Y Hsue; Kathleen Squires; Morris Schambelan; Peter W F Wilson; Kevin E Yarasheski; Colleen M Hadigan; James H Stein; Robert H Eckel
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

Review 3.  Management of human immunodeficiency virus infection in advanced age.

Authors:  Meredith Greene; Amy C Justice; Harry W Lampiris; Victor Valcour
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

4.  Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.

Authors:  Heloisa Sawaya; Igal A Sebag; Juan Carlos Plana; James L Januzzi; Bonnie Ky; Victor Cohen; Sucheta Gosavi; Joseph R Carver; Susan E Wiegers; Randolph P Martin; Michael H Picard; Robert E Gerszten; Elkan F Halpern; Jonathan Passeri; Irene Kuter; Marielle Scherrer-Crosbie
Journal:  Am J Cardiol       Date:  2011-03-02       Impact factor: 2.778

5.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

Review 6.  Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Authors:  Gerald S Bloomfield; Fawaz Alenezi; Felix A Barasa; Rebecca Lumsden; Bongani M Mayosi; Eric J Velazquez
Journal:  JACC Heart Fail       Date:  2015-08       Impact factor: 12.035

7.  Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

Authors:  Francesca J Torriani; Lauren Komarow; Robert A Parker; Bruno R Cotter; Judith S Currier; Michael P Dubé; Carl J Fichtenbaum; Mariana Gerschenson; Carol K C Mitchell; Robert L Murphy; Kathleen Squires; James H Stein
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

Review 8.  Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility.

Authors:  Melinda L Telli; Sharon A Hunt; Robert W Carlson; Alice E Guardino
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

9.  The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison.

Authors:  Eric J Velazquez; Zainab Samad; Hussein R Al-Khalidi; Chithra Sangli; Paul A Grayburn; Joseph M Massaro; Susanna R Stevens; Ted E Feldman; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2015-08-12       Impact factor: 4.749

10.  Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort.

Authors:  Nwora Lance Okeke; Fawaz Alenezi; Gerald S Bloomfield; Allison Dunning; Meredith E Clement; Svati H Shah; Susanna Naggie; Eric J Velazquez
Journal:  J Card Fail       Date:  2018-06-30       Impact factor: 5.712

View more
  2 in total

Review 1.  Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.

Authors:  Arjun Sinha; Matthew Feinstein
Journal:  Prog Cardiovasc Dis       Date:  2020-01-24       Impact factor: 8.194

2.  Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection.

Authors:  Matthew S Durstenfeld; Michael J Peluso; J Daniel Kelly; Sithu Win; Shreya Swaminathan; Danny Li; Victor M Arechiga; Victor Zepeda; Kaiwen Sun; Shirley Shao; Christopher Hill; Mireya I Arreguin; Scott Lu; Rebecca Hoh; Viva Tai; Ahmed Chenna; Brandon C Yee; John W Winslow; Christos J Petropoulos; John Kornak; Timothy J Henrich; Jeffrey N Martin; Steven G Deeks; Priscilla Y Hsue
Journal:  JCI Insight       Date:  2022-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.